Two Stocks Analysts are Expecting a July Breakout; Amid changes in Corporate Standing and NASDAQ Uplisting.

Although stocks have experienced a rough ride in 2019, some stocks still have a big chance to shine through the last quarter of 2019. The best stocks to buy now go above and beyond the normal growth prospects. While looking for these kinds of investments, we have examined 2 of the best micro-cap stocks to invest in, all with converging evidence that a breakout is just around the corner.

Meanwhile, there are stocks that already made huge gains over the past year, but could potentially double this year if they continue to execute well. Of course, the risk here is that these stocks are priced for perfection, and any missteps could be punished severely. Let’s look at five publicly traded companies that appear to have the potential to see their share prices double this year.

#1 Cuba Beverage Co (OTCMKTS: CUBV)

Laying low on the radar for most of 2019, Cuba Beverage Co (OTCMKTS: CUBV) has upside potential of over 300% say the Street’s top analysts which specialize in reinstatement and S1 analysis reports. Currently, the stock is trading at $0.0008 but analysts see it hitting $0.01 in the coming months. Currently the stock in a very promising setup and today it was just reinstated with the Wyoming Secretary of State. This represents a doctrinal shift in the company, as investors now await to hear where the company plans to go now it is reinstated.

#2 Innerscope Hearing Tech (OTCQB:INND)

Updated report via July 8, 2019

Recently, INND launched its own label of CDB Oil, (also referred to as Hemp Extract) (“CBD Oil”) a dietary supplement designed and marketed to the estimated 93 million current U.S. population (based on United States Demographic Profile 2018) 55+ age demographic who may desire the benefits from using CBD Oil. Matthew Moore, CEO of INND, had the following to say about its newly launched CBD line,

InnerScope also plans to market and distribute its branded CBD Oil to an estimated 15,000 Audiological and Hearing Aid Retail Clinics in the U.S (“Audiological Market”).

Interestingly, InnerScope plans to Increase its Retail Footprint within Northern California in 2019 by Ultimately Opening 25 Audiological Hearing Aid Retail Clinics to Augment its Continued Distribution Partnerships with and – This positions the company to be well within the revenue needed to compete with the four largest hearing aid companies in the world, with share prices up to $20.00 per share. This will also allow the company to effortlessly uplist to NASDAQ, bringing in a new and larger shareholder base to support a share price increase to the mandated $4.00 per share level.

Co-Founder and CEO Matthew Moore went on to give some insight into the big revenue numbers that are expected in the last quarter of 2019, further suggesting NASDAQ is only a matter of time, since OTCQB simply cannot handle these types of revenues.

Author: tradernewswire

Leave a Reply

Your email address will not be published. Required fields are marked *